Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 251661 - 251680 out of 498644 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Greece | (L01FD03) trastuzumab emtansine | KADCYLA PD.C.SO.IN 100MG BTx1VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FD03) trastuzumab emtansine | KADCYLA PD.C.SO.IN 160MG BTx1VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FD04) trastuzumab deruxtecan | ENHERTU PD.C.S.INF 100MG/VIAL 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | DAIICHISANKYOEUROPEGMBH,MUNICH,GERMANY |
| Greece | (L01FE02) panitumumab | VECTIBIX C/S.SOL.IN 100MG/5ML VIAL BT x 1 VIAL x 5 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AMGENEUROPEBV,BREDA,HOLLAND |
| Greece | (L01FE02) panitumumab | VECTIBIX C/S.SOL.IN 400MG/20ML VIAL BT x 1 VIAL x 20 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AMGENEUROPEBV,BREDA,HOLLAND |
| Greece | (L01FF03) durvalumab | IMFINZI C/S.SOL.IN 50MG/ML 1 vialx 2.4 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAAB,SOEDERTAELJE,SWEDEN |
| Greece | (L01FF03) durvalumab | IMFINZI C/S.SOL.IN 50MG/ML 1 vialx10 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAAB,SOEDERTAELJE,SWEDEN |
| Greece | (L01FF05) atezolizumab | TECENTRIQ C/S.SOL.IN 1200MG/VIAL (20ML) 1 VIAL x 20ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FF05) atezolizumab | TECENTRIQ C/S.SOL.IN 840MG/VIAL (14ML) 1 VIAL x 14ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FF06) cemiplimab | LIBTAYO C/S.SOL.IN 350MG/VIAL BTx1 vial x7 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | REGENERONIRELANDDESIGNATEDACTIVITYCOMPANY(DAC),IRELAND |
| Greece | (L01FF07) dostarlimab | JEMPERLI C/S.SOL.IN 500MG/VIAL 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Endometrial Neoplasms | GLAXOSMITHKLINE(IRELAND)LIMITED,IRELAND |
| Greece | (L01FG01) bevacizumab | ALYMSYS C/S.SOL.IN 25MG/ML VIAL x 16 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | MABXIENCERESEARCHSL,SPAIN |
| Greece | (L01FG01) bevacizumab | ALYMSYS C/S.SOL.IN 25MG/ML VIAL x 4 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | MABXIENCERESEARCHSL,SPAIN |
| Greece | (L01FG01) bevacizumab | AVASTIN C/S.SOL.IN 100 MG/4 ML BT x 1 VIAL x 4 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Breast Neoplasms;Ovarian Neoplasms;Colorectal Neoplasms;Carcinoma, Renal Cell;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Uterine Cervical Neoplasms | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FG01) bevacizumab | AVASTIN C/S.SOL.IN 400 MG/16 ML BT x 1 VIAL x 16 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Breast Neoplasms;Ovarian Neoplasms;Colorectal Neoplasms;Carcinoma, Renal Cell;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Uterine Cervical Neoplasms | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FG01) bevacizumab | MVASI® C/S.SOL.IN 25MG/ML 1 VIAL x 16ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Peritoneal Neoplasms;Ovarian Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Fallopian Tube Neoplasms | AMGENTECHNOLOGYIRELAND,DUBLIN,IRELAND |
| Greece | (L01FG01) bevacizumab | MVASI® C/S.SOL.IN 25MG/ML 1 VIAL x 4ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Peritoneal Neoplasms;Ovarian Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Fallopian Tube Neoplasms | AMGENTECHNOLOGYIRELAND,DUBLIN,IRELAND |
| Greece | (L01FG01) bevacizumab | OYAVAS C/S.SOL.IN 25MG/ML 1 VIAL x 4 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | STADAARZNEIMITTELAG,GERMANY |
| Greece | (L01FG01) bevacizumab | OYAVAS C/S.SOL.IN 25MG/ML VIAL x 16 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | STADAARZNEIMITTELAG,GERMANY |
| Greece | (L01FG01) bevacizumab | VEGZELMA C/S.SOL.IN 25MG/ML BT X 1 VIAL X 16ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | CELLTRIONHEALTHCAREHUNGARYKFT.,BUDAPEST,HUNGARY |
Pages
